Efficacy and safety of once-daily single-inhaler triple therapy in patients with inadequately controlled asthma: the CAPTAIN trial

Iñigo Ojanguren; María Florencia Pilia

doi:10.1183/20734735.0279-2020

Efficacy and safety of once-daily single-inhaler triple therapy in patients with inadequately controlled asthma: the CAPTAIN trial

Breathe (Sheff). 2021 Mar;17(1):200279. doi: 10.1183/20734735.0279-2020.

Authors

Iñigo Ojanguren^{1

2

3}, María Florencia Pilia¹

Affiliations

¹ Servei de Pneumología, Hospital Universitari Vall d´Hebron, Departament de Medicina, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
² Institut de Recerca (VHIR), Barcelona, Spain.
³ CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain.

Abstract

Triple therapy with FF/UMEC/VI improved lung function in patients with moderate or severe uncontrolled asthma on ICS/LABA but did not lead to a reduction in moderate and/or severe exacerbations https://bit.ly/38UnuRW.